Velarion Records
Free. Unsubscribe any time.

Monte Rosa Therapeutics, Inc. (GLUE)

Monte Rosa Therapeutics, Inc. filed 16 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 4 reporting owners, covering 21 transactions and 106,170 shares. 16 carry the SEC's AFF10B5ONE flag; 0 name a plan only in a footnote. No results print is on file in this window, so no interval is measured.

What stands out

Trades in Monte Rosa Therapeutics, Inc. 21

Adoption dates in Monte Rosa Therapeutics, Inc. 4

Results prints in Monte Rosa Therapeutics, Inc. 0

Trades before a print in Monte Rosa Therapeutics, Inc. 0

Interval to Monte Rosa Therapeutics, Inc.’s next reported results date

How the interval and sources are counted →

Adoption dates Monte Rosa Therapeutics, Inc. states

Filing text: “10b5-1 trading plan adopted on May 14, 2025”

Sources: SEC EDGAR full-text search and the SEC submissions API.